Answers are grounded in this paper and cite their sources.
Demonstrates improved organophosphorus detoxification in human cell lines, indicating enhanced safety and efficacy.
We have investigated the impact of pig liver esterase biomimetic mineralization into Esterase@Zeolitic Imidazolate Frameworks (Esterase@ZIF) nanoparticle biocomposites, on crystal phase stability, external particle surface reactivity and biocompatibility. Control over Zn 2+ /2-methylimidazole (mImH) ratio during esterase promoted biomineralization allowed us to obtain Esterase@Zn(mIm) 2 (Esterase@ZIF-8, 3D sodalite, microporous) monodisperse biocomposite nanoparticles of 60 nm and 120 nm sizes. The crystal surface reactivity of Esterase@ZIF-8 biocomposites was assessed for the hydrolytic decontamination of methylparaoxon (MP). We have also evaluated the ability of crystal surface structural degradation products to neutralize the inhibitory effect of MP on Acetylcholinesterase (AChE) activity. These experiments have been carried out under simulated physiological conditions (Tris-HCl, pH = 7.4) as a model of organophosphorus detoxification. Finally, we have assessed the cytotoxicity of biocomposites towards SH-SY5Y human neuroblastoma, HEK 293 Human embryonic kidney and HEP-G2 Hepatocellular Carcinoma cell lines to evaluate the biocompatibility of Esterase@ZIF-8 during organophosphorous poisoning treatment. The results show the benefit of esterase biomineralization leading to improved crystal phase stability, enhanced organophosphorus detoxification and lower cytotoxicity indicative of increased nanoparticle biocompatibility in comparison to pristine ZIF materials. These results exemplify that biomineralization can be used not only to protect enzymes from harsh environments but also to modulate crystal surface reactivity and biocompatibility.
No takes yet. Share an insight, caveat, or question.
Borrego-Marin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: